| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2017NatCo...8.1601P |
| P356 | DOI | 10.1038/S41467-017-01640-Y |
| P932 | PMC publication ID | 5693931 |
| P698 | PubMed publication ID | 29150603 |
| P50 | author | Ian A Wilson | Q87680387 |
| Ralph Pantophlet | Q89306380 | ||
| Paul Kosma | Q41464649 | ||
| P2093 | author name string | Sasha Murrell | |
| Caitlin Rempel | |||
| Dennis Chau | |||
| Naiomi Lu | |||
| Nino Trattnig | |||
| P2860 | cites work | Few and far between: how HIV may be evading antibody avidity | Q21090507 |
| Printed covalent glycan array for ligand profiling of diverse glycan binding proteins | Q24559665 | ||
| Complete nucleotide sequence of the membrane form of the human IgM heavy chain | Q24609964 | ||
| Knockout rats via embryo microinjection of zinc-finger nucleases | Q24633888 | ||
| MolProbity: all-atom structure validation for macromolecular crystallography | Q24649111 | ||
| pdb-care (PDB carbohydrate residue check): a program to support annotation of complex carbohydrate structures in PDB files | Q24798795 | ||
| The HIV glycan shield as a target for broadly neutralizing antibodies | Q26786540 | ||
| A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield | Q27675032 | ||
| Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120 | Q27678306 | ||
| Coot: model-building tools for molecular graphics | Q27860505 | ||
| UCSF Chimera--a visualization system for exploratory research and analysis | Q27860666 | ||
| Towards automated crystallographic structure refinement with phenix.refine | Q27860678 | ||
| Phasercrystallographic software | Q27860930 | ||
| Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipic acid dihydrazide | Q71705428 | ||
| Differential Antibody Responses to Conserved HIV-1 Neutralizing Epitopes in the Context of Multivalent Scaffolds and Native-Like gp140 Trimers | Q37695592 | ||
| A bacterial lipooligosaccharide that naturally mimics the epitope of the HIV-neutralizing antibody 2G12 as a template for vaccine design. | Q38327409 | ||
| Immunological Outcomes of Antibody Binding to Glycans Shared between Microorganisms and Mammals | Q39013747 | ||
| Identification and specificity of broadly neutralizing antibodies against HIV | Q39108796 | ||
| HIV-1 Virus-Like Particles Bearing Pure Env Trimers Expose Neutralizing Epitopes but Occlude Nonneutralizing Epitopes | Q39402539 | ||
| Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice | Q39407795 | ||
| Immune perturbations in HIV-1-infected individuals who make broadly neutralizing antibodies | Q40103798 | ||
| Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide. | Q40290511 | ||
| A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging Glycans. | Q40606158 | ||
| Affinity Dependence of the B Cell Response to Antigen: A Threshold, a Ceiling, and the Importance of Off-Rate | Q41027647 | ||
| Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV. | Q42215329 | ||
| Human antibody expression in transgenic rats: comparison of chimeric IgH loci with human VH, D and JH but bearing different rat C-gene regions | Q44182322 | ||
| Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system | Q45746979 | ||
| Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission | Q47878972 | ||
| Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis | Q48761076 | ||
| Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120. | Q28217208 | ||
| Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity | Q28378893 | ||
| High-affinity IgG antibodies develop naturally in Ig-knockout rats carrying germline human IgH/Igκ/Igλ loci bearing the rat CH region | Q28709119 | ||
| 9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activity | Q28730532 | ||
| GLYCOSCIENCES.de: an Internet portal to support glycomics and glycobiology research. | Q30482956 | ||
| Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance | Q33591736 | ||
| Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates | Q33612459 | ||
| Defining criteria for oligomannose immunogens for HIV using icosahedral virus capsid scaffolds | Q33840789 | ||
| Reducing V3 Antigenicity and Immunogenicity on Soluble, Native-Like HIV-1 Env SOSIP Trimers | Q33907694 | ||
| Oligosaccharide chains are trimmed during synthesis of the envelope glycoprotein of vesicular stomatitis virus | Q33961274 | ||
| The presence of glutamine at position 315 but not epitope masking predominantly hinders HIV subtype C neutralization by the anti-V3 antibody B4e8. | Q34017550 | ||
| The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120. | Q34342352 | ||
| Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer | Q34565029 | ||
| Antibodies against gangliosides: a link between preceding infection and immunopathogenesis of Guillain-Barré syndrome | Q34574505 | ||
| N332-Directed broadly neutralizing antibodies use diverse modes of HIV-1 recognition: inferences from heavy-light chain complementation of function | Q34594978 | ||
| Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12. | Q34781840 | ||
| Two classes of broadly neutralizing antibodies within a single lineage directed to the high-mannose patch of HIV envelope | Q34991017 | ||
| Defined conjugation of glycans to the lysines of CRM197 guided by their reactivity mapping | Q35116917 | ||
| Crystal structure of the HIV neutralizing antibody 2G12 in complex with a bacterial oligosaccharide analog of mammalian oligomannose | Q35119778 | ||
| Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa | Q35140032 | ||
| MF59 adjuvant enhances antibody responses of infant baboons immunized with Haemophilus influenzae type b and Neisseria meningitidis group C oligosaccharide-CRM197 conjugate vaccine | Q35546445 | ||
| Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors | Q35857221 | ||
| Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites | Q35913681 | ||
| Endogenous antigen tunes the responsiveness of naive B cells but not T cells | Q36223587 | ||
| Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switching | Q36557966 | ||
| Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice. | Q36627503 | ||
| A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind to the self glycans of gp120 | Q36748055 | ||
| Human plasma protein N-glycosylation | Q36963945 | ||
| An engineered mutant of HIV-1 gp120 formulated with adjuvant Quil A promotes elicitation of antibody responses overlapping the CD4-binding site | Q37069430 | ||
| Immune Tolerance Negatively Regulates B Cells in Knock-In Mice Expressing Broadly Neutralizing HIV Antibody 4E10 | Q37171251 | ||
| Mapping the complete glycoproteome of virion-derived HIV-1 gp120 provides insights into broadly neutralizing antibody binding | Q37240035 | ||
| Immunization with Outer Membrane Vesicles Displaying Designer Glycotopes Yields Class-Switched, Glycan-Specific Antibodies | Q37425396 | ||
| Progress toward active or passive HIV-1 vaccination | Q37549777 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | infectivity | Q1662346 |
| alpha-D-Manp-(1->2)-alpha-D-Manp-(1->3)-alpha-D-Manp | Q27139646 | ||
| alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc | Q27139648 | ||
| P304 | page(s) | 1601 | |
| P577 | publication date | 2017-11-17 | |
| P1433 | published in | Nature Communications | Q573880 |
| P1476 | title | Bacterially derived synthetic mimetics of mammalian oligomannose prime antibody responses that neutralize HIV infectivity | |
| P478 | volume | 8 |
| Q89859143 | A convenient synthesis of short-chain α-(1 → 2) mannopyranosyl oligosaccharides |
| Q90677040 | Antibody responses to the HIV-1 envelope high mannose patch |
| Q90411066 | Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques |
| Q60908253 | Comparative antigenicity of thiourea- and adipic amide linked neoglycoconjugates containing modified oligomannose epitopes for the carbohydrate-specific anti-HIV antibody 2G12 |
| Q92932606 | Comparisons of the antibody repertoires of a humanized rodent and humans by high throughput sequencing |
| Q92006841 | Cooperation between somatic mutation and germline-encoded residues enables antibody recognition of HIV-1 envelope glycans |
| Q63362961 | Oligomannose Glycopeptide Conjugates Elicit Antibodies Targeting the Glycan Core Rather than Its Extremities |
| Q64983102 | Protein and Glycan Mimicry in HIV Vaccine Design. |
| Q94554546 | Serum alpha-mannosidase as an additional barrier to eliciting oligomannose-specific HIV-1-neutralizing antibodies |
| Q64099089 | Synthesis of an Undecasaccharide Featuring an Oligomannosidic Heptasaccharide and a Bacterial Kdo-lipid A Backbone for Eliciting Neutralizing Antibodies to Mammalian Oligomannose on the HIV-1 Envelope Spike |
| Q89936366 | The Impact of Sustained Immunization Regimens on the Antibody Response to Oligomannose Glycans |
Search more.